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Clinical studkr have demonstrated I rignificantly reduced 
incidence of sudden cardiac death in ptkntr treated titb 
implantable cardiove~er&Rbrilkton (I-6). Much cd this 
data derives horn experience with early gencationr of im- 
plantable cardkwerter-dcfibrilltdo~ that provided limited pm- 
gmmmability, diagnostic capabilities and data storage (733). 
The rapld tcchncdogic evolution of impbmtabls cardiwcrkr. 
dcfibrillators bar been dirccld toward ioccnporatily anti- 
t&ycmdia pacing and low energy crwdiovcrsbm capabilities to 
both minimize pticm discomfort and atend battery life, 
refIttint? tachycnti detection algorithms uod mainbinlng I 
high degree of &xcy in the preventiOn of .wl&n cnrdii 
de& (2.3). However, optimal utiliition of multiple implonr- 
able mrdiirtcr-defdxillatot therapies tquires on improved 
uMktsl8ndio# of the pattum CA “se dnting bmg-kzml folklw- 
up. The capacity of an implantabte cardbvater&6britb3tor to 
8toi-c information shout Irhycudia dmatioor and thcmpii 
thos assumes great importance. lids study &scrikr the 
insights gained into clinical implantable cardioverter- 
dcfibrillata utllkatbn by tbc data smmgc capacities of a 
late+wwatimt device do@ a lorgc multiccnta clii trial. 
Methedn 
Amitachycardia pacing rhempy. The Prugrrmmahlc 
Automatic Scanning Arrhylhmin Rcvuniun-Orthur~lhnli~ 
(PASAR-0) algo&nm d&cm a smies of pub trains (I to ?I) 
pulses. I to NJ mins) wirh il dccmmcntal inilial bwpling 
intewnl bavca the lurt scared kut of taehycnrdbs and Ihc 
and p.xgnun.nubk minimal and m&Gnal initial inwvilb (?a1 
to 4fN ms). The Jccrcmcm bclwcn pulrcs wkhin wulrrvculiw 
trains iz dewmincd by tk erwammzd maximad and minimal 
,mupling imawls (6&X t;CXI% of lachycwJia cycle length). 
The last succerrlul antimcbwardia oxinn train k recalled and 
used I initial Uwapy $I &bsequ&d tu&xdii~. Antiwhy 
cardia paciy-bxbxed accelcmtiun al the tachycudin cyek 
length by z-50 mr or tu shock thcrnpy is dwumcacd Qy the 
incmmcnt to YW, and except for the &I number oi shoc’ks 
dcliwcd. may bc xsct to zero by the programmer. Relrkv- 
able cpiscdc k# shlrc vey &l&d infurmadon nhnut indi- 
vidual txhycxdii dettiiow. including date. rime and cycle 
length at deeclion. as well us d&Is about the numhcr of 
xntitirhycardia pwily hxim and shwb delivend lu each 
cpiwde. lntmwdiuc ekctmgmms can lx recorded and stored 
immcdistcly after ~acbycnnlin dctccdon and rwcnion. Eke 
trgmms can he stored for at least six tachyardia detections 
(depending on ~gmmming) bcforc mrmwy wcmitinl: oc- 
LUt-5. 
Patient rrlectbn Guardinn ATP 42lU devicrr were im- 
plantrd a~ 53 centus in nine cwnlries (IU). Rewms for 
pzxicnt inclusion and cxclusinn have been previously published 
i I :). Erh palien1 gave informed wilten c&sent to pu’ticipale 
in rhc study pmloml. which ws approved by Ihe lnrliheinal 
kuicx llk;d ut csCh implunr&~ ucnicr. 
hplmtatian andfollow-up Dwicc implantation was per- 
iormd with tn wiihnul wncamitanf cardiac surgery and has 
hcen dwrihrd cluwhcx (IU). Implantation required three 
consecutive succasful ventricu!ar fibrillation terminations at 
energies alll J helow lhc maximal output of fhc device. After 
iapknmtinn. patiert follow-up was rqdred befors hospital 
discharge and at 2 and 4 month and then at 1~1 every 6 
moathr (9). Dalibrillation testing was pzforr?d be-fore bos- 
pital discharge and at 4 months after bnplai:atioo if no 
wca~ul spontanews shock tbcrapy had been delfvered. 
Cardiinion threshold testing and antilaehycardn pat@ 
teaing wrc attempted before hqdtal ditchmge. gpfxi6c 
testing of antitachymrdia pacing was nut qubzd before 
zztivation of this therapy. TIE study pmtoml allowd anpirk 
programming of antitacbywdia pa@ variabka in @knts 
with demented dinkal sustained matomotphk vcntrkakr 
tcstig sfttx device implantation. %xhyrard&belcctionr n- 
suiting from ekctmphysiologic w dwke testing WA not 
included in this analysis. 
clawmtlon d qontanmms deJedims. cks%ifwtion of 
detections as due to vantticalar tacbyarrbytbmiPs. sapmvea- 
tricular tacbycardias or nob in the absettcc of elarmrdio- 
gmphic doc~mentalion foUmvcd pwiously pablishcd ctitcria 
(E-14). Detections wen cla%lRed as wwfculw tadlyfwdfa if 
acmmpankd Ly rynmpe. pfc-synwpa, ty$al pmdmmal m 
tomwofvcntrieulartsr*ycsrdiaforagivenptientnrbd~a 
changes in con6ganti~ 01 stwd ekztqmms. Vennfcufar 
~76riffutfon was diagaosad if the recorded mean RR interval was 
~150 ms sad was accompaaied by symptoms of bemodynamk 
mmpmmise or changes in the configuration of stomd ekctm- 
grams. Sirtw taclp~ was dkgnosed if &tcctiom oatned 
with physical eacrtion likely to cause sinus tachycnrdfa aad 
without wmvtoms. Dc~ectiunr wem classified as N&I WiJfa- 
rion if irk&r predetection RR intmvak were &ded 
without symptoms of vmtrkular tacbyarrhythmirs or without 
change in configuration of avallabk stored ckchograms. 
Other supmwtufcufar mdtycurdim were diagamad MI the 
regular iR iat&& at the sama ardrmmented s~ptavaa~ 
tricular afrhdhmiss. The diilicullv of dkaami~ rtmnwttrk- 
alat mthyth&v in the obacncc if attial”~co&gs’wca with 
vmtrkulsr ekctrognms has been t’emgnkcd in pm*us rlad- 
ies (13). Noise detectkin wcrc classified by imgtdsr elogly 
coupkd RR intervals (CM rra) that mrc rcpmdwed by 
manipulation of the d&c ot lead or mr oswciated with 
other evidence of lead ot gctwatar malfaaction. 
Attcmptrrmre made todafsiily alldatectiatson lbabasisof 
all available data; hxww. previous stadies have documented 
the dillictdty in classifying asymptnmatk nottsastaiaad cwnts 
(13,141. Nonsustained awmptomatk detections were classitkd 
by an independent rev& of thr data by the implanting 
physkinn and the central data collection center (Tckatonics 
Pacing Systems). If still unck~r. these wemswerc dwifkd as 
sag&ted athe&. Discrepancies in intetpfctatiom ware 
resolved by discwsion until maluat qrcameat was tea&ad. 
8tatiiicr. The Cxa ngrcssion model was used to analyze 
univnriate and multivariate mlstiom bctwan the patient din- 
iml characteristics and &RbrilkWr activity during followup 
aad various death clawitknticnr Variables measured during 
tba cowsa of follow-up (id.:. numbar of sbwbs, tacbymrdia 
datectiom and twtcd detactiom [shack or antitachycardk 
pae~)aro~donane~~r~y~(~~aumber 
of events ravrtdcd diGdad b, total datatioa of follow-up) fot 
aacb patknt m mtttml fordlffarattcas in dutali~n of fdlowtp 
Thecvent~dROlS~day.O~~~dcpirodcsld~ 
(ahocbs 01 a&zbycxdla pacbt8) ad 0.09 detutbm#day 
were &cted to glcup patients with rloazem 6aquencks into 
appmab~~ately equal lvo~ps with aa equal lo* incidcnoc (at 
*as1 tba attoE fquaacy) and a higb ineiderre (bigbet than 
the catol3 ftequency) tiw cacb wiabk. Patients nith a am 
frqwxy la chase events wate incladad in lba lw fnqueacy 
group. E4tbaates of I.yaar monaMty rates were dollaccd 
hadontheQarnodela~fundmnofthncwiabks;pc 
f&l5 was coasbbtral signifkaat. 
Reaultr 
8tadypatlmtlr. Atotald4OlGuardian42lOATPd&es 
wta implatucd in 393 patiettts at the 53 cantats betwea 
December 4. I989 and May I. 1992. Follow-UP data were 
colkcted tbmu& June 1. i992. Lkmograpbk~data for all 
@kn:r and indkationr la device implantation are ti in 
Table 2 ‘Jltc system of dam cdkction used d.&fkd each 
inplant as a sapatate patbat. Far cmtsistancy this systam is 
maintained titmugbout this report (aote that 8 [2%] of the 
393 patkttts bad hvo device implatttatiom). Mean @eat 
folkw-up paioa WBI %B days (tanga 1 to 769). 
ftt atkiitii 106 ptttlcttts (26%) had 25.167 Ltectioits dot 
to awscs &I then rcntricuhu tachycnrdis or ventricular 
Brillatkm, includbtg dctc&m due to external. tea& or 
conncctof-gettcraicd wise (43 patients). supmvenuicolar 
trcbyctiol (rS patients~ doobk wming of wide QR5 com- 
plexes (3 patbxts) and ttttd&tcd causes (23 patients). Ninety- 
three percetm of sptuious dctectiom dii not result in the 
deliiry of tbcrapy; hmvcver, 92 of these padcnts (67%) 
tweiwd antitachycudia pclng or shock therapy due to spu- 
tima detect&s. 
Tnchwrdla m- Of the 66276 total w+ictdar 
tach~cxdia or fibrillation cletcctions (excludktg noise, ow- 
sensmg and supmveo~riculsr mchymrhythmia Ctcctions), 
74.4% spontaneously rewled by the time of fir.1 contirmrdion, 
22.1% nwcrted after antitichjwdia potin& 1.7% rcwrted 
after shock therapy, and 1.7% were late reversions (reversion 
doting dwrgingbmbefaerr~~ds~kdel~e~). 
Of the 281 patients with tachjwdii detections 266 (95%) 
experienced one or toore spontanwur mnions. The pro- 
gmmmed shock delay was 5 and 10 s in 81% and 18% of the 
paticnrx wpectively. Of the 15,734 C:ations lecciving thw 
opy. 93% reverted after antitachycudia pacing therapy and 7% 
alter shock therapy. A sommiy of all tz’.qrardii met&ma is 
shown in Figure 1. 
Antii padng lhempy. Antitach~wlii F&teing 
was enabled in 266 patients doting follm.up. One hwdtcd 
filly patients R&&I antitachy&lia pacing therapy during 
follow-up. Fwthm Fnt of peticntr rsrrb-ing antitachy- 
cardia pacing thempy had ihis modality forto&ly tested before 
activation. The remain& 47% of patients had antihchycaxlta 
pacing activated with w&g of &gtomntable ontitxhycardia 
pacing variables detemdncd empirically or on the basis of 
socccssfitl pace teiminatiotts a elccbop*logic t*dinB 
Ttx~cditt termination follmvcd antitacitycxdia pacing 
theraw in %% of 15.285 episodcr. cod 94.5% of pationtn 
,i& antimhymrdiu paring had one or more s&ssLl 
antitachycadia pacing mwsion. Acc&xdlions to shock Iher- 
npy acc?vcd in 1.3% of epsoda and 46 patients (30.5%). Of 
these 46 patients eqwienciny tnchvcardia accelerations, 36 
had formal atttitachycardia pacing @Sting before accclw?tions 
were recorded, an&IO had no ar;titach)rardia pacing Ming. 
The average cycle length cf ventticulu txhycardia treated by 
aotito&ycardia psting was 388 2 74 ins. Maxhnal initial 
mupling intervals of 90% or 65% of the tacbycardia cycle 
tsngtb were set L, 89% of patients. The mean pmgmmmrd 
minimril mupliig interval was 70%. The wragc maximal 
numberdlmimtobcdcliveredvrr5 f 2 
Sbnck Ibempy. Shock themq was delivered (a l.lU2 (7%) 
of 15,734 total cpis&s ofvcntdadar racbyarrbythmlls web. 
ing lbwapy. Sewnty-eight parent of all 221 padcnls rcwiving 
sny thcwpy sapxicnced one or more nbcda Cnmpktc epi- 
sode Ioes were availabk IO Ihc data collecdon center for 329 
& fibrillation initialing &ck therapy in do awl 16 patients. 
rcspenivcly. Late nwmions duriw capacitor cbar@g 0~. 
curred in 9% and 53% cd 1bcac vcn~ricular t~ehycardia nd 
wmtricular Ahr’Mion cpisaks, w+w.cMy. Allhougb 111~ 
remeining 21 cpiwdcn of wami~lar fibrillation were all kr- 
ainatcd by IWO or Icss sJwcka. 6% d fberc wntricuiar la&y- 
cardia cpiswkr rcqubed three or more shocks to termiwte 
(Fii 3). A suurmary of all 91,443 implantabk cardioverkr. 
delibrilhmx dekctiu~~r is shown in Fiire A 
Bradyardia tbaapy. Bradycadir pacing therapy was cn- 
abled al sane point during fdlow~up in 3% patknu (99%). A’ 
implantaden. 30% of all patients utilii postsbcck bmdycar- 
dia support pacing tith a mean pmgmmmd hwer mu: of 
55 2 9 bat&tin. F*-seven percent of padents utiliied 
bradycardir rupporl pacins due lon@mn followup, as 
documenkd by the counter for percent of bradyadia suppxt 
tiw 
Pati rurvival. Among the 401 study @en@., 34 (R76) 
died during f&w-up (audden cardiac death in 5. wasudden 
cardile death io 16, noncardiac in I I, unknown elido~v in 2 16 
classified by a committee of independent mims). Sudden 
cardiac. death w defined as dealh dcardix origin occurring 
within I h d onscl of new rgnptoms or unwimewd death i* 
the absence of 6 clear noncardiac tiolosy. The pvalur. for the 
~swciation of total mmlaliiy (n = 34). and total cardiac (n = 
21) and nancardiac (n = 13) mortality. with various clinical 
variables and implantable nrdiowler-dofibtillalar detections 
we skavn in Table 3. Bah total and cardisc mortplity were 
anclated si@cantly with reduced ejection fraclian New 
York Hcan Assccfatitm ftmctiinal heart faii class at im 
plan6~ion higher frqueney af shocks (>aUlS shock&) and 
higher frequency of any deliwed therapy (XX325 treated 
cphodg/day) ay tmivariale analysb (all p e 0.026). Total 
monslii was alw cmr&ed with incmlring age (p = 01)lS). 
The erlimatcd l-year menality nts ‘based on tbe Cm m&I 
as 6 functioll d there clinical wiabks M shown in T&k 3. 
For csampls fhc mud4 cslimater that pdcws titb an ejce 
don fracth d 25% bad a l-year total mortality rate of II%. 
whcrclw tbm with an ejection fmciioa d 4O% had au II% 
1-r total mortality TIC. The higlw probpbilides d total 
and cardiac mwtalily mm aswciated with clias 1V hem! 
failun (34% and 28% I-yar mortality nuch rerprrivcly) snd 
hi frqucncy of rbab (19% and 16% l-ycvr murkdily rates. 
rerpaiwly). By multivaririrtr an@+ only lhc frequcmy d 
shock therapy vu a.wciacd wbh mort&y (p = OIQ7). The 
paraihilii d frequent shacks far lmninal evrnts rcganlkss d 
mtnc cannot he excluded Y a mow of this awciation. Thb 
tttt+.iic amoot be used to iacl trentmcd bcnctit. 
Diiussion 
The mk OF the i~laot&dc cotdkwcrtcr-del%xf!!xx in the 
t~atmettt of tecotm~t malfgomt ventriculu arrhythmias ;md 
areadIoS patfmt rotvivol is widely rccogttized (6.15). How- 
cwt. detaikd koowlcdgc alxwt the pattctcms ood prognmtic 
hnplfftfoos of implaotahle mrdfowrtcr-defibrillator utilizn- 
lioo were ottwaffle belaa iomrpomtion OF dttta-lc@i 
capaMities into the devices tbem*lves. Iltii study describes 
the ootatte of 66,276 spotttaoeolrr veotriculor txhymrhyth- 
o&i dcteclions recwded in P group of 393 ptttiettt~ aftor 
hnokmtotion of the Tcbxtmnin Guardian 4210 impktota5k 
&dioverter&flbrilfator. Tlure data o&r oew i&hts into 
the demaods placed on these d&cl. 
SpDluollls ddaffme ood twmfoaftooa. Consistent with 
art early report by Loccri et al. (16), these data demonstrate 
that tnchyr;uJia detccdons may be Far more frequent than the 
inckfma of rkaks may suggest. From the data in this report. 
75% of all tachpxdia debxtions terminated spmmtt~wt~@. 
and US5 of all patients with deteciiotts experienced om or 
more spunt;meow terminations. Thcsc mtnmon nomustaiocd 
cpboda are the likely raw of many *indeterminate” shocks 
in prcviou audiis wing mmmittcd dcvim; howcvcr. the 
current patient group may ret%xt proportionally fewer p;lticnts 
with mrdhc artrat than pmious so&s (S). It is clear that to 
minimix inappropriate shocks e&&e tachyc&a nxon- 
limtation is ‘&se&d for any impluntablc~cotdiovctter- 
drlibrilkttor. ‘IWe ttlgorithmr should include late reconfit’ma- 
tkm during capacitor charging and should even be applied to 
mpid vcntrictdor tebytwrhythmias (17). 
Spurious detectIons. Previous studies with both cnrly- 
and -late .generstion implnnloble mrdimwter_detibriMtors 
(~.?,S.l&tP) topmted that 9% to 2U% of patients receive 
therapy from tmplat~tahle mdioverterdefibtiliaton for dctec- 
dons other that1 vmtrfctdar tacbyarrhylhmie. In this study, 
26% of sll prtients nwnied spmious debxdm~s, most am- 
manly due to su7mventrkxdar tachycardias. Althqb only 7% 
of these cpisudes acrually resulted in therapy deliwy. 878 of 
that 
tbenpy, blappmpriarely &lkercd therapy remains P common 
pmbkm. Altbough cady twugnilion of spwfous detations by 
data logging may allow corrective meastwa u) be l&en before 
inappmpriate therapy is rludly delivered, more &dike 
diwiminatinn of supmventricular iachynrdi and further 
imprwrment in saing leads and oJmwtw8 IO minimize the 
ocaunna of noirc are we&d (119). 
The krg r&o&d hen 
ellkacy d antitachycardia p t!@ lhempy nen wkea em@ic 
mmming is used. Altbwgh empiric pmgmmming is nul 
adwcnted by our group, B slgnifwnt number of patiws who 
may bene6t from anritnchvcpnlio pa&x cannot hw the 
cardin pa&g m Ibis study. 76% of paienta roeivir* my 
tkerqy experienced at least one chock. Again, pmganvning 
will inflnenee this prceent, but this underscores the need for 
cUeeWe sbo* therapy in all plients. The riced for reliabk 
s&k therapy is funhr capknsized by the 6ndir.g tka16% of 
ventrktdar tachyrardia :piales receiving shock thempy I- 
quired three or more shccka to terminate. &se da18 suggest 
thsi mare than four sbccks per epkuk may be lwded from 
implantable cardicwmerde6bdlJators or tha: the e.&q of 
initkd shocks ne& impmvemmt. or Lu4.b. The availn~ of 
biphasic &arks may address the Inner problem (25). 
Prqndcimpllmthr d~detetthr.Re- 
viom invWiga!ion into the pmgnuslk value of defibrillamr 
discbarnes is limii Mverbura et al. f26! drmonankd a 
with absolite caiaimy. Tbis tep&nls a limitation of al! 
dellbrilltior sMcs to date that use smwd data to dt.& 
etiologkr d anrdcd de&ii itmmrdir el& 
may be uncha@ during vatrkulnr whyzmdia in up to 
7% of patient8 and may lbow s!gniit con6gunttil 

